COBAS INTEGRA 400 PLUS
Report
- Report Number
- 1823260-2010-02768
- Event Type
- Malfunction
- Date Received
- May 7, 2010
- Date of Event
- April 23, 2010
- Report Date
- October 4, 2010
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- JGS
- PMA / PMN Number
- K951595
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KS, US
- Reporter Occupation
- MEDICAL TECHNOLOGIST
Narratives
IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA. (B) (4)
THE INVESTIGATION DETERMINED THAT THE CUSTOMER PERFORMS SODIUM ANALYSIS ON THIS ANALYZER USING AN INDIRECT ISE MODE. THE CUSTOMER WAS COMPARING THESE RESULTS WITH THOSE FROM AN ANALYZER THAT USED A DIRECT ISE MODE. DUE TO THE SOLVENT EXCLUSION EFFECT IT IS NOT POSSIBLE TO COMPARE RESULTS OBTAINED THROUGH INDIRECT ISE MEASUREMENT WITH THOSE OBTAINED THROUGH DIRECT ISE MEASUREMENT.
THE CUSTOMER ALLEGED QUESTIONABLE SODIUM RESULTS ON 7 PATIENT SAMPLES, 3 OF WHICH WERE FOUND TO BE DISCREPANT. PATIENT 1: FEMALE, DATE OF BIRTH 11/10/1935 COBAS INTEGRA 400 PLUS SODIUM = 131 MMOL/L ALTERNATE METHOD SODIUM = 141 MMOL/L PATIENT 2: MALE, (B) (6) COBAS INTEGRA 400 PLUS SODIUM = 130 MMOL/L ALTERNATE METHOD SODIUM = 136 MMOL/L PATIENT 3: FEMALE, (B) (6), NOT PREGNANT COBAS INTEGRA 400 PLUS SODIUM = 134 MMOL/L ALTERNATE METHOD SODIUM = 141 MMOL/L SODIUM ISE LOT NUMBER: 21594916 THE CUSTOMER STATED THAT NONE OF THE DISCREPANT RESULTS WERE REPORTED OUTSIDE THE LABORATORY AND THEREFORE, NO PATIENTS WERE AFFECTED BY THE RESULTS. THE FIELD SERVICE REPRESENTATIVE REPLACED THE SODIUM ELECTRODE AND PERFORMED ELECTRODE SERVICE AND RECOMMENDED MAINTENANCE. THE CUSTOMER PERFORMED CALIBRATION AND QUALITY CONTROLS WERE RUN AS WELL AS A CORRELATION STUDY WITH PATIENT SPECIMENS. THE CUSTOMER WAS SATISFIED WITH THE RESULTS.
DURING AN IMPLANT PROCEDURE, A PHYSICIAN FOUND IMPEDANCE MEASUREMENTS TO BE GREATER THEN 10,000 OHMS USING AN EXTERNAL NERVE STIMULATOR DEVICE. THE PATIENT DID NOT FEEL ANY STIMULATION. THE PHYSICIAN TRIED TO RECONNECT THE LEAD TO THE TEMPORARY EXTENSION SEVERAL TIMES. IN ADDITION, THE PHYSICIAN TRIED TO PERFORM TEMPORARY STIMULATION USING THEIR SCREENING DEVICE (MODEL 3625). REGARDING BOTH TYPES OF ATTEMPTS NOTED, THE PATIENT STILL WAS UNABLE TO FEEL ANY PARESTHESIA. IT WAS INDICATED THAT THE LEADS WERE INITIALLY IMPLANTED WITHOUT DIFFICULTY. AN ALTERNATE NEW LEAD WAS IMPLANTED, AND THE FIRST IMPEDANCE MEASUREMENTS RESULTED IN BEING GREATER THAN 10,000 OHMS ALSO. HOWEVER, AFTER RECONNECTING THE LEAD AGAIN, THE PATIENT STARTED TO FEEL STIMULATION AND ALL IMPEDANCE MEASUREMENT BECAME NORMAL. THE PATIENT WAS NOTED TO HAVE "OK" WITHOUT ANY INJURY. ADDITIONAL INFORMATION WILL BE PROVIDED IN A FOLLOW-UP, AS IT BECOMES AVAILABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | COBAS INTEGRA 400 PLUS | CLINICAL CHEMISTRY ANALYZER | JGS | ROCHE DIAGNOSTICS | NA | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 074 YR | LIPITOR -DAILY| COLACE - DAILY| CENTRUM SILVER| ALTACE - DAILY| SPIRIVA| METAMUCIL - DAILY| TYLENOL - PRN| CITRUCEL DAILY| DILTIAZEM - DAILY| "APIRIN" DAILY| ALLEGRA - ONCE DAILY| ADVAIR - TWICE DAILY| ALBUTEROL - DAILY| SINGULAIR - DAILY| "MILK OF MAG" - PRN| PRILOSEC - DAILY| EFFEXOR - DAILY| DIAZEPAM - PRN |